A carregar...
Interleukin-35 limits anti-tumor immunity
Regulatory T (Treg) cells pose a major barrier to effective anti-tumor immunity. Although Treg cell depletion enhances tumor rejection, the ensuing autoimmune sequelae limits its utility in the clinic and highlights the need for limiting Treg cell activity within the tumor microenvironment. Interleu...
Na minha lista:
| Publicado no: | Immunity |
|---|---|
| Main Authors: | , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4758699/ https://ncbi.nlm.nih.gov/pubmed/26872697 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.immuni.2016.01.013 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|